Authors: Heike, Y Kasono, K Kunisaki, C Hama, S Saijo, N Tsuruo, T Kuntz, DA Rose, DR Curiel, DT

Citation: Y. Heike et al., Overcoming multi-drug resistance using an intracellular anti-MDR1 sFv, INT J CANC, 92(1), 2001, pp. 115-122

Authors: Kasono, K Heike, Y Xiang, JL Piche, A Kim, HG Kim, M Hagiwara, M Nawrath, M Moelling, K Curiel, DT

Citation: K. Kasono et al., Tetracycline-induced expression of an anti-c-Myb single-chain antibody andits inhibitory effect on proliferation of the human leukemia cell line K562, CANC GENE T, 7(1), 2000, pp. 151-159

Authors: Kasono, K Blackwell, JL Douglas, JT Dmitriev, I Strong, TV Reynolds, P Kropf, DA Carroll, WR Peters, GE Bucy, RP Curiel, DT Krasnykh, V

Citation: K. Kasono et al., Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector, CLIN CANC R, 5(9), 1999, pp. 2571-2579

Authors: Suzuki, T Piche, A Kasono, K Xiang, JL Gomez-Navarro, J Moriuchi, S Krisky, DM Oligino, T Glorioso, JC Curiel, TJ Curiel, DT

Citation: T. Suzuki et al., Efficient gene delivery into Epstein-Barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy, BIOC BIOP R, 252(3), 1998, pp. 686-690